January 3, 2022 – HighLife’s TSMVR Technology successfully used for the first time in China
HighLife SAS, a medtech company focused on the development of a unique Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe mitral regurgitation (MR), announced …